Stay ahead in medical device regulation with this targeted course on the FDA’s classification of herpes simplex virus (HSV) nucleic acid-based assays for central nervous system infections. Gain actionable insights into the specific special controls required for Class II devices, from design and clinical validation to quality assurance and regulatory documentation. Learn how these controls streamline market access while ensuring device safety and effectiveness, making this training essential for anyone involved in the development, testing, or regulatory submission of diagnostic assays.
In this course you will learn the following:
* Understand the classification process and criteria for the herpes simplex virus nucleic acid-based assay.
* Identify the special controls required for compliance.
* Recognize the impact of this classification on regulatory burdens and patient access to innovative devices.
